Home >Current Issue
Volume: 9, Issue: 2, February, 2019
Treatment patterns of antipsychotics and clinical features for treating patients with schizophrenia at the teaching hospital in Jakarta, IndonesiaAuthor Affiliations
Antipsychotics are a group of psychotropic drugs used as the mainstay treatment for schizophrenia. In Indonesia, studies on the pattern of drug use are still limited, particularly about the rational use of antipsychotics for schizophrenic patients. This study was aimed to discuss the treatment patterns of antipsychotics and clinical features of inpatients with schizophrenia. This retrospective study was conducted at the psychiatric ward of a tertiary hospital in Jakarta, Indonesia. The medical records of the inpatients in a year period were recorded. The evaluation of rational use of antipsychotics was assessed using clinical pathway in the hospital and some international guidelines. The data were documented by using specific forms for the sake of this study. In this study, of the 113 analyzed patients, the most common type of schizophrenia was paranoid, while the common antipsychotics were risperidone (63.7%), haloperidol (20.4%), and quetiapine (19.5%). Surprisingly, we found that 73.4% of patients met one or more criteria of inappropriateness treatment and majority cause of inappropriateness were inappropriate indication (41.6%). In this study, we find out that schizophrenia inpatients were administered to a large number of inappropriate treatments. Knowledge regarding the implementation of clinical pharmacology contributions to the psychiatrists might improve the prescription’s pattern.
Copyright: The Author(s). This is an open access article distributed under the Creative Commons Attribution Non-Commercial License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Banerjee I, Roy B, Sathian B, Banerjee I, Chakraborty PK, Saha A. Socio demographic profile and utilization pattern of antipsychotic drugs among schizophrenic inpatients: a cross sectional study from western region of Nepal. BMC Psychiatry, 2013; 13:96. https://doi. org/10. 1186/1471-244X-13-96
Barnes, TR, Paton C. Antipsychotic polypharmacy in schizophrenia: benefits and risks. CNS Drugs, 2011; 25:383–99. https://doi. org/10. 2165/11587810-000000000-00000
Bole CB, Pišlar M, Šen M, Tavčar R, Mrhar A. Switching antipsychotics: results of 16-month non-interventional, prospective, observational clinical research of inpatients with schizophrenia spectrum disorders. Acta Pharm, 2017; 6:99–112. https://doi. org/10. 1515/acph-2017-0001
Borison RL, Pathiraja AP, Diamond BI, Meibach RC. Risperidone: clinical safety and efficacy in schizophrenia. Psychopharmacol Bull, 1992; 28:213–8.
Department of Psychiatry, Cipto Mangunkusumo Hospital, Guideline on "The Management of Schizophrenia," 2015 (2nd Revised Edition). Famuyiwa OO. Psychotropic drug prescription in Nigeria. Acta Psychiatr Scand, 1983; 68:73–81. https://doi. org/10. 1111/j. 1600-0447. 1983. tb06984. x
Gaebel W, Riesbeck M, Wobrock T. Schizophrenia guidelines across the world: a selective review and comparison. Int Rev Psychiatry, 2011; 23:379–87. https://doi. org/10. 3109/09540261. 2011. 606801
Hálfdánarson Ó, Zoëga H, Aagaard L, Bernardo M, Brandt L, Fusté AC, et al. International trends in antipsychotic use: a study in 16 countries, 2005-2014. Eur Neuropsychopharmacol, 2017; 27:1064–76. https://doi. org/10. 1016/j. euroneuro. 2017. 07. 001
Huang CL, Hwang TJ, Chen YH, Huang GH, Hsieh MH, Chen HH, et al. Intramuscular olanzapine versus intramuscular haloperidol plus lorazepam for the treatment of acute schizophrenia with agitation:an open-label, randomized controlled trial. J Formos Med Assoc, 2015; 114:438–45. https://doi. org/10. 1016/j. jfma. 2015. 01. 018
Igbinomwanhia NG, Olotu SO, James BO. Prevalence and correlates of antipsychotic polypharmacy among outpatients with schizophrenia attending a tertiary psychiatric facility in Nigeria. Ther Adv Psychopharmacol, 2017; 7:3–10. https://doi. org/10. 1177/2045125316672134
Kopala LC. Spontaneous and drug-induced movement disorders in schizophrenia. Acta Psychiatr Scand Suppl, 1996; 389:12–7. https://doi. org/10. 1111/j. 1600-0447. 1996. tb05943. x
Kreyenbuhl J, Buchanan RW, Dickerson FB, Dixon LB. Schizophrenia Patient Outcomes Research Team (PORT). The Schizophrenia Patient Outcomes Research Team (PORT): updated treatment recommendations 2009. Schizophr Bull, 2010; 36:94–103. https://doi. org/10. 1093/schbul/sbp130
Lehman AF, Kreyenbuhl J, Buchanan RW, Dickerson FB, Dixon LB, Goldberg R, et al. The schizophrenia Patient Outcomes Research Team (PORT): updated treatment recommendations 2003. Schizophr Bull, 2004; 30:193–217. https://doi. org/10. 1093/oxfordjournals. schbul. a007071
Meyer JM. Pharmacotherapy of psychosis and mania. In: Goodman, Gilman (eds. ). The pharmacological basis of therapeutics. 2nd edition, McGraw-Hill, New York, NY, pp 409–39, 2011.
Nielsen J, Jensen, SO, Friis RB, Valentin JB. Correll CU. Comparative effectiveness of risperidone long-acting injectable vs firstgeneration antipsychotic long-acting injectables in schizophrenia: results from a nationwide, retrospective inception cohort study. Schizophr Bull, 2015; 41:627–36. https://doi. org/10. 1093/schbul/sbu128
National Guideline on Psychiatry Services. Indonesian Psychiatric Association, 2012. NICE. Psychosis and schizophrenia in adults: treatment and management. Available via http://www. nice. org. uk/Guidance/CG178(Accessed 29 September 2017).
Owen MJ, Sawa A, Mortensen PB. Schizophrenia. Lancet, 2016; 388:86–97. https://doi. org/10. 1016/S0140-6736(15)01121-6
Park SC, Lee MS, Kang SG Lee SH. Patterns of antipsychotics prescription to patients with schizophrenia in Korea: results from the health insurance review & assessment service-national patient sample. J Korean Med Sci, 2014; 29:719–28. https://doi. org/10. 3346/jkms. 2014. 29. 5. 719
Pompili M, Baldessarini RJ, Forte A, Erbuto D, Serafini G, Fiorillo A, et al. Do atypical antipsychotics have antisuicidal effects? A hypothesis-generating overview. Int J Mol Sci, 2016; 17. https://doi. org/10. 3390/ijms17101700
Seeman P, Tallerico T. Antipsychotic drugs which elicit little or no parkinsonism bind more loosely than dopamine to brain D2 receptors, yet occupy high levels of these receptors. Mol Psychiatry, 1998; 3:123–34. https://doi. org/10. 1038/sj. mp. 4000336